Medtronic plc (MDT), a healthcare technology company, on Monday announced that it has completed its acquisition of privately held medical device company CathWorks in a deal valued at $585 million, with a possibility of potential undisclosed earn-out payments.
The purchase follows a 2022 co-promotion agreement and adds CathWorks'FFRangio System to Medtronic's cardiovascular portfolio.
Medtronic said the transaction is expected to be immaterial to fiscal 2027 GAAP and adjusted earnings per share and neutral to accretive thereafter.
On the New York Stock Exchange, shares of Medtronic are currently trading 0.61 percent higher at $86.72
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.